Nasdaq Axsm News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nasdaq axsm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nasdaq Axsm Today - Breaking & Trending Today
Meridian Wealth Management LLC raised its holdings in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 6.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 20,498 shares of the company’s stock after purchasing an additional 1,275 shares during […] ....
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) is set to issue its quarterly earnings data before the market opens on Monday, May 6th. Analysts expect the company to announce earnings of ($1.22) per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link. Axsome […] ....
Moody Aldrich Partners LLC lowered its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 9.2% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 66,866 shares of the company’s stock after selling 6,767 shares during the period. Moody Aldrich Partners LLC owned approximately 0.14% […] ....
Moody Aldrich Partners LLC reduced its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 9.2% in the fourth quarter, Holdings Channel reports. The firm owned 66,866 shares of the company’s stock after selling 6,767 shares during the period. Moody Aldrich Partners LLC’s holdings in Axsome Therapeutics were worth $5,322,000 at the […] ....
HC Wainwright reissued their buy rating on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a report released on Tuesday morning, Benzinga reports. They currently have a $190.00 price objective on the stock. Other analysts have also recently issued reports about the company. UBS Group initiated coverage on Axsome Therapeutics in a report on […] ....